“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives” (2024) International Journal of Pharmaceutical Sciences and Drug Research, 16(3), pp. 378–386. doi:10.25004/IJPSDR.2024.160309.